ArticleCurrent oncology (Toronto, Ont.)2025

The Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Lenvatinib and Programmed Death (PD)-1 Inhibitors for Unresectable Intrahepatic Cholangiocarcinoma: A Retrospective Study.

Yingxiao Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.